Paraoxonase, anti-oxidant response and oxidative stress in children with chronic renal failure

被引:25
作者
Ece, A [1 ]
Atamer, Y
Gürkan, F
Davutoglu, M
Bilici, M
Tutanç, M
Günes, A
机构
[1] Dicle Univ, Fac Med, Dept Pediat, Diyarbakir, Turkey
[2] Dicle Univ, Fac Med, Dept Biochem, Diyarbakir, Turkey
[3] Sutcu Imam Univ, Fac Med, Dept Pediat, Kahramanmaras, Turkey
[4] State Hosp, Malatya, Turkey
关键词
albumin; children; chronic renal failure; cytokines; oxidative stress; paraoxonase;
D O I
10.1007/s00467-005-2079-2
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Increased oxidative stress is believed to contribute to an increased risk of cardiovascular disease in uraemia. In children with chronic renal failure (CRF), an anti-oxidant enzyme, paraoxonase (PON), that inhibits oxidation of LDL-cholesterol, has not been previously investigated. In this study we aimed to investigate PON activity, total anti-oxidant response (TAR), total peroxide (TPX), oxidative stress index (OSI) and some pro-oxidant cytokines in 29 children with CRF [mean age 10.2 +/- 3.5 years; 19 pre-dialysis, ten on continuous ambulatory peritoneal dialysis (CAPD)] and in 25 control subjects. Children with CRF had lower PON and TAR and higher TPX and OSI values than did controls (P<0.05). Except for lower TAR and serum albumin levels of the CAPD subgroup (P<0.05), other parameters were similar in non-dialysis and CAPD patients (P>0.05). Patients had significant positive correlation between TAR and serum albumin (P<0.05). Serum urea had significant positive correlation with TPX and OSI (P<0.05). Increased oxidative stress and decreased anti-oxidants measured by serum PON activity and TAR were found in children with CRF. We can hypothesize, on the basis of statistical correlations, that low levels of serum albumin and high levels of uraemic metabolites might be responsible for increased oxidative stress in children with CRF. Further studies with larger sample sizes are needed to verify these results.
引用
收藏
页码:239 / 245
页数:7
相关论文
共 30 条
[1]  
Annuk M, 2001, CLIN NEPHROL, V56, P308
[2]   Premature cardiovascular disease in chronic renal failure [J].
Baigent, C ;
Burbury, K ;
Wheeler, D .
LANCET, 2000, 356 (9224) :147-152
[3]  
Dantoine TF, 1998, J AM SOC NEPHROL, V9, P2082
[4]   Oxidative stress in patients with end-stage renal disease prior to the start of renal replacement therapy [J].
Diepeveen, SHA ;
Verhoeven, GHWE ;
van der Palen, J ;
Dikkeschei, BLD ;
van Tits, LJ ;
Kolsters, G ;
Offerman, JJG ;
Bilo, HJG ;
Stalenhoef, AFH .
NEPHRON CLINICAL PRACTICE, 2004, 98 (01) :C3-C7
[5]  
Dirican M, 2004, J NEPHROL, V17, P813
[6]   Oxidative stress in patients with chronic renal failure:: Effects of hemodialysis [J].
Durak, I ;
Kaçmaz, M ;
Elgün, S ;
Öztürk, HS .
MEDICAL PRINCIPLES AND PRACTICE, 2004, 13 (02) :84-87
[7]   A novel automated method to measure total antioxidant response against potent free radical reactions [J].
Erel, O .
CLINICAL BIOCHEMISTRY, 2004, 37 (02) :112-119
[8]   Clinical epidemiology of cardiovascular disease in chronic renal disease [J].
Foley, RN ;
Parfrey, PS ;
Sarnak, MJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :S112-S119
[9]   SPECTROPHOTOMETRIC ASSAYS FOR THE ENZYMATIC-HYDROLYSIS OF THE ACTIVE METABOLITES OF CHLORPYRIFOS AND PARATHION BY PLASMA PARAOXONASE ARYLESTERASE [J].
FURLONG, CE ;
RICHTER, RJ ;
SEIDEL, SL ;
COSTA, LG ;
MOTULSKY, AG .
ANALYTICAL BIOCHEMISTRY, 1989, 180 (02) :242-247
[10]   Antioxidant therapy in uremia: Evidence-based medicine? [J].
Gordon, CA ;
Himmelfarb, J .
SEMINARS IN DIALYSIS, 2004, 17 (05) :327-332